Seer Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 11:40PM GMT
Derik De Bruin - BofA Securities, Research Division - MD of Equity Research

Good afternoon, everyone. Welcome to the 2022 Bank of America Healthcare Conference, live from beautiful Las Vegas. Nice to see everybody here. I'm Derik De Bruin, the Senior Life Sciences and Diagnostic Tools Analyst for Bank of America. And now for something completely different, let's talk proteomics, here we are today with Seer. And with us from Seer is Chief Executive Officer and Founder, Omid Farokhzad, and CFO, David Horn. Gentlemen, thank you for being here. Thank you for coming in to be with us today.

Questions and Answers:

Derik De Bruin - BofA Securities, Research Division - MD of Equity Research

So start off with the question and we were just chatting about this. You guys were the first proteomics company to go public, and then there was this wave of other companies that went public. And I think one of the questions I get from investors is, how do you sort of differentiate all these companies? So can you sort of put Seer in the competitive landscape and sort of would
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot